A Phase II Study of Lonafarnib in Patients With Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 19 Feb 2016
At a glance
- Drugs Lonafarnib (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 01 Nov 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 09 Nov 2008 New trial record.